PH12022552709A1 - Agent for improving quality of sleep - Google Patents

Agent for improving quality of sleep

Info

Publication number
PH12022552709A1
PH12022552709A1 PH1/2022/552709A PH12022552709A PH12022552709A1 PH 12022552709 A1 PH12022552709 A1 PH 12022552709A1 PH 12022552709 A PH12022552709 A PH 12022552709A PH 12022552709 A1 PH12022552709 A1 PH 12022552709A1
Authority
PH
Philippines
Prior art keywords
sleep
agent
improving quality
improving
quality
Prior art date
Application number
PH1/2022/552709A
Other languages
English (en)
Inventor
Kazuhiko Kawaguchi
Takanori Mizuno
Tetsuya Sakurai
Satomi Yamasaki
Original Assignee
Nippon Chemiphar Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Chemiphar Co filed Critical Nippon Chemiphar Co
Publication of PH12022552709A1 publication Critical patent/PH12022552709A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/03—Organic compounds
    • A23L29/035—Organic compounds containing oxygen as heteroatom
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/31—Foods, ingredients or supplements having a functional effect on health having an effect on comfort perception and well-being
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00—Food ingredients
    • A23V2250/02—Acid
    • A23V2250/032—Citric acid

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Nutrition Science (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Anesthesiology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Mycology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Zoology (AREA)
  • Physiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Bakery Products And Manufacturing Methods Therefor (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
PH1/2022/552709A 2020-04-14 2021-04-13 Agent for improving quality of sleep PH12022552709A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2020072192 2020-04-14
JP2020123385 2020-07-20
PCT/JP2021/015273 WO2021210565A1 (ja) 2020-04-14 2021-04-13 睡眠の質の改善剤

Publications (1)

Publication Number Publication Date
PH12022552709A1 true PH12022552709A1 (en) 2024-04-22

Family

ID=78084866

Family Applications (1)

Application Number Title Priority Date Filing Date
PH1/2022/552709A PH12022552709A1 (en) 2020-04-14 2021-04-13 Agent for improving quality of sleep

Country Status (12)

Country Link
US (1) US20230149330A1 (https=)
EP (1) EP4137206A4 (https=)
JP (2) JPWO2021210565A1 (https=)
KR (1) KR20230005819A (https=)
CN (1) CN115397262A (https=)
AU (1) AU2021257176A1 (https=)
BR (1) BR112022020334A2 (https=)
CA (1) CA3175207A1 (https=)
IL (1) IL297227A (https=)
MX (1) MX2022012735A (https=)
PH (1) PH12022552709A1 (https=)
WO (1) WO2021210565A1 (https=)

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4913410B1 (https=) 1970-05-29 1974-03-30
CN1172645A (zh) * 1997-07-18 1998-02-11 杨巍 柠檬酸盐溶石液及其制备方法
KR100379596B1 (ko) * 1999-09-13 2003-04-10 주식회사 한국팜비오 구연산칼륨을 주제로 한 요로결석치료제의 제조방법
JP3907964B2 (ja) * 2001-04-25 2007-04-18 株式会社 伊藤園 精神疲労軽減組成物、集中力維持増強組成物及び精神的活力維持増強組成物
KR20120120423A (ko) 2004-01-14 2012-11-01 아지노모토 가부시키가이샤 글리신을 함유하는 식품 및 이의 용도
EP1743633B1 (en) * 2004-04-06 2010-08-18 Taiyokagaku Co., Ltd. Use of a combination of theanine and serotonin for sleep disorders
JP2007230954A (ja) * 2006-03-02 2007-09-13 Fancl Corp 睡眠誘導剤及びストレス性不眠症改善剤
JP2009023948A (ja) * 2007-07-19 2009-02-05 Pokka Corp ドーパミン抑制剤
JP5282202B2 (ja) * 2008-04-11 2013-09-04 成都金麒麟生物健康科技有限公司 抗ストレス剤または睡眠改善剤
PL2712622T3 (pl) * 2008-05-21 2017-01-31 Ferring B.V. Ulegająca rozpadowi w ustach desmopresyna do zwiększania początkowego okresu snu niezakłócanego przez nokturię
JP2014172892A (ja) * 2013-03-12 2014-09-22 Fujifilm Corp 睡眠改善剤、ノンレム睡眠時間増加剤及び鎮静剤
MX352660B (es) * 2013-03-15 2017-12-04 Univ New York Bebida con contenido de citrato.
US20150087679A1 (en) * 2013-09-20 2015-03-26 Hany Helmi Nutritional sleep supplement
JP6976515B2 (ja) 2017-07-21 2021-12-08 国立大学法人 筑波大学 睡眠改善剤
JP7231898B2 (ja) 2018-09-26 2023-03-02 ビーエイチエヌ株式会社 睡眠の質改善剤
US20210369654A1 (en) * 2018-10-16 2021-12-02 Nippon Chemiphar Co., Ltd. Agent for improving quality of sleep
EP3868370A4 (en) * 2018-10-17 2022-06-29 Nippon Chemiphar Co., Ltd. Therapeutic or prophylactic agent for nocturia
JP7192399B2 (ja) 2018-10-31 2022-12-20 Tdk株式会社 薄膜キャパシタ
JP6815547B2 (ja) 2020-04-21 2021-01-20 株式会社フジタ 床振動解析プログラムおよび床振動解析装置

Also Published As

Publication number Publication date
IL297227A (en) 2022-12-01
CA3175207A1 (en) 2021-10-21
JP2025172167A (ja) 2025-11-20
BR112022020334A2 (pt) 2022-11-22
AU2021257176A1 (en) 2022-11-10
EP4137206A4 (en) 2024-05-22
US20230149330A1 (en) 2023-05-18
KR20230005819A (ko) 2023-01-10
WO2021210565A1 (ja) 2021-10-21
CN115397262A (zh) 2022-11-25
EP4137206A1 (en) 2023-02-22
JPWO2021210565A1 (https=) 2021-10-21
MX2022012735A (es) 2022-11-07

Similar Documents

Publication Publication Date Title
Allen et al. Selenium sulfide: adjunctive therapy for tinea capitis
Sher et al. Acute myopathy with selective lysis of myosin filaments
CN111419787A (zh) 一种氯喹喷剂及其制备方法
JP2020073606A (ja) 非イオン性シリコーンハイドロゲルコンタクトレンズ用点眼剤
JP2016088844A (ja) 組成物
AU2013339058B2 (en) Agent for preventing or improving decline in brain function
JP3175742B1 (ja) コンタクトレンズ用眼科用組成物
Tatipamula et al. Anti-inflammatory properties of Dirinaria consimilis extracts in albino rats
PH12022552709A1 (en) Agent for improving quality of sleep
Bear et al. β-hydroxy-β-methylbutyrate supplementation in older persons–an update
RS49772B (sr) Farmaceutske kompozicije
WO2020170032A3 (en) Method for treatment of rosacea in patients aged 65 years and older
CN107412312A (zh) 一种治疗勃起功能障碍的男性保健组合物
US10973919B2 (en) Vitamin preparation
PH12023550900A1 (en) Oral combined formulation including gemigliptin and dapagliflozin and preparation method therefor
Toronto Aerosolized Pentamidine Study (TAPS) Group Acute pulmonary effects of aerosolized pentamidine: a randomized controlled study
JP2003073303A (ja) 眼局所用液剤の清涼化作用の持続方法
Ferrer et al. A nasal spray solution of grapefruit seed extract plus xylitol displays virucidal activity against SARS-Cov-2 in vitro
JP2017071600A (ja) くすぶり炎症抑制剤
KR100880537B1 (ko) 칸탈로프 멜론추출물과 글리아딘 결합물을 유효성분으로 하는 기억, 집중력, 학습능력 개선제
US6270756B1 (en) Weight loss induced by alpha interferon and gamma interferon
US20210260039A1 (en) Nutritional compositions for enhancement of muscle performance
Ciświcka-Sznajderman et al. The effect of combined treatment with phenformin and stanazolol on blood lipids and fibrinolytic activity in patients with hypertriglyceridaemia
Torres-Larrosa et al. Nasal leprosy: impact of multitherapy in the morphology and physiology of the nose
US20160361333A1 (en) Use of citrus polyphenol for wound healing and composition thereof